Supplementary Figure S4 from Molecular and Pathologic Characterization of YAP1-Expressing Small Cell Lung Cancer Cell Lines Leads to Reclassification as SMARCA4-Deficient Malignancies | Synapse
May 1, 2024Open Access
Supplementary Figure S4 from Molecular and Pathologic Characterization of YAP1-Expressing Small Cell Lung Cancer Cell Lines Leads to Reclassification as SMARCA4-Deficient Malignancies
Key Points
Key points are not available for this paper at this time.
Abstract
H&E and immunohistochemistry of cell line xenografts H661, H1581 and SBC5.